Enfermedad pulmonar obstructiva crónica: Resultados del tratamiento inhalado regula en pacientes GOLD A
Kompass Neumología · 2020
DOI: 10.1159/000504907 ↗Abstract
Background: The 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends regular bronchodilator therapy in all group A patients with chronic obstructive pulmonary disease (COPD). Objective: The aim of this study was to evaluate whether regular inhaled treatment in group A patients with COPD improves their health outcomes, including exacerbations and symptoms. Methods: We recruited patients from 2 Korean prospective cohorts. Eligible COPD patients had a modified Medical Research Council (mMRC) dyspnea score of
EUVIMED